NCT02268253
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02268253
Title Tagraxofusp (SL-401) in Patients With CMML or MF
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Stemline Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of California, San Francisco Clovis California 93611 United States Details
City of Hope Duarte California 91010 United States Details
University of California, Los Angeles Los Angeles California 90095 United States Details
Stanford Cancer Institute Stanford California 94305 United States Details
Mayo Clinic Florida Jacksonville Florida 32224 United States Details
Georgia Cancer Center at Augusta University Augusta Georgia 30912 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
Indiana Blood and Bone Marrow Transplantation Indianapolis Indiana 46237 United States Details
University of Kansas Cancer Center Westwood Kansas 66205 United States Details
Norton Cancer Institute Louisville Kentucky 40207 United States Details
Dana Farber Cancer Institute (DFCI) Boston Massachusetts 02114 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
University of Michigan Health System Ann Arbor Michigan 48109 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
John Theurer Cancer Center Hackensack New Jersey 07601 United States Details
University of New Mexico Albuquerque New Mexico 87106 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Weill Cornell Medical Center New York New York 10021 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
The Ohio State University Columbus Ohio 43210 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
University of Alberta Edmonton Alberta T6G 2G3 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field